Thus, the loss of p53 function in cancer can (i) increase the activity of cytokines and their receptors (migration and proliferation), (ii) sustain an abnormal response to inflammatory stimuli (angiogenesis and matrix degradation), and (iii) facilitate a tumour-promoting microenvironment [172,173,174]. The gene discussed is TP53; the disease is cancer.